REGENXBIO Inc (RGNX) insider trading
Every open-market stock purchase and sale by REGENXBIO Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Gregory Austin Ciongoli (Insider) bought $949K in the last 90 days, more than doubling their stake.
Last 12 months: insiders bought $949K (1 buy) and sold $940K (4 sales). Last close $7.17 on Oct 22, 2026.
Recent RGNX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 1, 2026 | Mitchell Chan (CFO) | Sold (not open market) | $45.7K |
| Sep 1, 2026 | Craig Malzahn (CTO) | Sold (not open market) | $2.2K |
| Aug 27, 2026 | Gregory Austin Ciongoli (Insider) | Bought | $500K |
| Aug 26, 2026 | Gregory Austin Ciongoli (Insider) | Bought | $450K |
| Aug 25, 2026 | Gregory Austin Ciongoli (Insider) | Bought (not open market) | — |
| Aug 25, 2026 | Gregory Austin Ciongoli (Insider) | Bought (not open market) | — |
| Aug 1, 2026 | Steve Pakola (C-suite exec) | Sold (not open market) | $72.4K |
| Aug 1, 2026 | Patrick J. Christmas (Officer) | Sold (not open market) | $45.5K |
| Jul 2, 2026 | Steve Pakola (C-suite exec) | Sold | $29.5K |
| Jul 2, 2026 | Steve Pakola (C-suite exec) | Bought (not open market) | — |
| Jul 1, 2026 | Steve Pakola (C-suite exec) | Sold | $472K |
| Jul 1, 2026 | Steve Pakola (C-suite exec) | Bought (not open market) | $289K |
| Jul 1, 2026 | Curran Simpson (CEO) | Sold (not open market) | $89.2K |
| Jul 1, 2026 | Steve Pakola (C-suite exec) | Bought (not open market) | — |
| Jun 30, 2026 | Curran Simpson (CEO) | Bought (not open market) | $14.8K |
| Jun 29, 2026 | Steve Pakola (C-suite exec) | Sold | $216K |
| May 29, 2026 | Allan M. Fox (Insider) | Bought (not open market) | — |
| May 29, 2026 | Kenneth T. Mills (Insider) | Bought (not open market) | — |
| May 29, 2026 | Jennifer Zachary (Insider) | Bought (not open market) | — |
| May 29, 2026 | Daniel Tasse (Insider) | Bought (not open market) | — |
| May 29, 2026 | George V Migausky (Insider) | Bought (not open market) | — |
| May 29, 2026 | George V Migausky (Insider) | Bought (not open market) | — |
| May 29, 2026 | Jean Bennett (Insider) | Bought (not open market) | — |
| May 29, 2026 | Jennifer Zachary (Insider) | Bought (not open market) | — |
| May 29, 2026 | Alexandra Glucksmann (Insider) | Bought (not open market) | — |
Who's trading RGNX
- Craig Malzahn, CTO: other filings, last Sep 1, 2026
- Mitchell Chan, CFO: other filings, last Sep 1, 2026
- Gregory Austin Ciongoli, Insider: bought $949K (2 buys), last Aug 27, 2026
- Steve Pakola, C-suite exec: sold $940K (5 sales), last Aug 1, 2026
- Patrick J. Christmas, C-suite exec: other filings, last Aug 1, 2026
- Curran Simpson, CEO: other filings, last Jul 1, 2026
- David C Stump, Insider: other filings, last May 29, 2026
- Jennifer Zachary, Insider: other filings, last May 29, 2026
- Allan M. Fox, Insider: other filings, last May 29, 2026
- Alexandra Glucksmann, Insider: other filings, last May 29, 2026
- Argeris N Karabelas, Insider: other filings, last May 29, 2026
- George V Migausky, Insider: other filings, last May 29, 2026
- Kenneth T. Mills, Insider: other filings, last May 29, 2026
- Daniel Tasse, Insider: other filings, last May 29, 2026
- Jean Bennett, Insider: other filings, last May 29, 2026
Get free alerts when an insider at REGENXBIO Inc files a new trade →